GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 22 filers reported holding GAIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 123,000 | $385 | 0.61% |
CM Management, LLC | 110,000 | $344 | 0.41% |
Greenlight Capital | 546,560 | $1,710,732 | 0.12% |
Wealth Alliance Advisory Group, LLC | 18,751 | $58,691 | 0.02% |
PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $181,853 | 0.01% |
Cannell Capital | 12,371 | $38,721 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $187,800 | 0.01% |
HOEY INVESTMENTS, INC | 500 | $1,565 | 0.00% |
TWO SIGMA SECURITIES, LLC | 12,742 | $39,882 | 0.00% |
Tower Research Capital LLC (TRC) | 7,152 | $23 | 0.00% |